Pressroom: Facts & Figures

Memorial Sloan Kettering Cancer Center is the world’s oldest and largest private cancer center, devoting more than 130 years to exceptional patient care, innovative research, and outstanding educational programs.

The following facts and figures reflect our reputation for scientific excellence and our commitment to finding better approaches to preventing, diagnosing, and treating cancer. 

Who We Are

  • Recognized Nationally – The National Cancer Institute has designated Memorial Sloan Kettering as one of only 41 comprehensive cancer centers in the country, underscoring our multidisciplinary cancer research program, expert faculty, and state-of-the-art facilities.
  • Clinical Staff – Our staff of 12,402 dedicated and talented employees includes 876 attending physicians and 2,133 registered nurses.
  • Researchers – We have more than 100 laboratory investigators, 149 senior faculty members, 320 research fellows, 533 postdoctoral researchers, and 243 graduate students (both PhDs and MD/PhDs).
  • Educators – We are training future physicians, scientists, and nurses who will continue to fight cancer on every front around the world. In 2012, we trained 1,682 residents and clinical fellows; 533 postdoctoral research fellows, research scholars, and research associates; 222 PhD candidates; 21 MD/PhD candidates; 178 nursing students; and 431 medical students.

Patient Care

  • Teamwork – We take a unified approach to cancer care, with more than a dozen Disease Management Teams of multidisciplinary specialists who work together to guide each patient through diagnosis, treatment, and recovery. Our specially trained oncology nurses work closely with our physicians to provide compassionate patient-centered care, foster a safe and healing environment, and offer support and comfort to our patients and their loved ones.
  • SpecializationOur physicians treat more than 400 different subtypes of cancer each year, rendering a level of specialization that can have an often dramatic effect on our patients’ chances for a cure or control of their disease. Our nurses bring extraordinary knowledge, experience, and expertise to the care they give to our patients with cancer.
  • PathologyOur pathologists analyze some 40,000 tumor samples each year to determine a precise diagnosis and the extent of disease (called staging) — an essential step to deciding the best course of treatment.
  • Screening – More than 15,519 cancer screenings were performed at Memorial Sloan Kettering in 2012. Memorial Sloan Kettering’s Breast Examination Center of Harlem has screened more than 200,000 women for breast cancer at no cost to those screened since it opened in 1979.
  • Our Patients – In 2012, nearly 131,000 patients were seen at all of Memorial Sloan Kettering’s locations, with more than 24,500 admitted to Memorial Hospital. Our Manhattan and regional facilities also accommodated 541,474 outpatient visits.

Research and Discovery

  • Scientific Excellence – Our investigators include 12 members of the National Academy of Sciences, 18 Institute of Medicine members, one National Medal of Science winner, seven Howard Hughes Medical Institute investigators, two Lasker Award recipients, and one winner of the Wolf Prize in Chemistry.
  • Biomedical Research Leader – We are one of the nation’s leading centers for biomedical research, bringing together scientists and physicians to solve critical problems in cancer biology and human health.
  • Drug Development – Between 1980 and 2012, the US Food and Drug Administration approved ten drugs developed in our labs for marketing — a success rate not matched by any other cancer center. In fact, a study led by Boston University ranked Memorial Sloan Kettering one of the top three public-sector research organizations in the discovery of new therapeutic products, after the National Institutes of Health’s intramural program and the ten-campus University of California.
  • Basic and Translational Research – Our basic laboratory research activities are organized around eight major research programs focused on advancing knowledge in the biomedical sciences and making discoveries aimed at improving our understanding of cancer and ultimately benefiting patients. We also have an extensive hospital research program in which our scientists focus on translational research that bridges discoveries made in the laboratory and those made in the clinic, as well as on mathematical and computational research directed at analyzing and interpreting biomedical data.
  • Clinical Research – We conduct one of the largest clinical research programs in the world, all aimed at improving the prevention, diagnosis, and treatment of cancer. In December 2012, our physicians were leading 1,141 clinical research studies for pediatric and adult cancers.
  • Collaborative Research – Drawing on the breadth of its scientific expertise, Memorial Sloan Kettering brings together laboratory investigators and clinicians from different disciplines within our institution to create centers without walls that focus on key areas in cancer research. Moreover, our investigators work with scientists from other institutions — such as the Broad Institute of MIT and Harvard, Cold Spring Harbor Laboratory, The Rockefeller University, Weill Cornell Medical College, and City College of New York — allowing us to gain valuable insight from researchers who are also exploring new ways to cure, control, and prevent disease.

Education and Training

  • Leaders in Life Sciences and Medicine – A vital part of our mission, our training, graduate, and continuing education programs prepare the next generation of physicians, scientists, nurses, and other healthcare professionals for leadership roles in the life sciences and medicine, especially as related to cancer.
  • Partnering with Top Institutions – Our educational collaborations with The Rockefeller University, Cornell University, and Weill Cornell Medical College offer PhD programs in chemical biology, computational biology and medicine, and the medical sciences. Memorial Sloan Kettering also partners with Weill Medical College and The Rockefeller University to offer an MD/PhD program for aspiring physician-scientists.
  • Preparing Basic Scientists – The Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences offers a PhD degree in cancer biology, training gifted basic laboratory scientists to work in research areas directly relevant to cancer and other human diseases. We also offer postdoctoral research fellowships that provide scientists with advanced laboratory research training.
  • Educating Physicians – We offer postgraduate clinical fellowships to train physicians who seek special expertise in a particular type of cancer. With faculty appointments at the Weill Cornell Medical College, our clinical staff members also train residents and medical students.
  • Commitment to Nurses – We are committed to improving the quality of care for cancer patients through the professional development and education of nurses at Memorial Sloan Kettering. We value their efforts to achieve advanced degrees and national certifications in their specialty practices, keep pace with technological and scientific advances in oncology nursing, and play leadership roles in the ongoing development of the profession.
  • Training the Next Generation – We offer a variety of educational and training programs for high school and college students who aspire to careers in medicine and science. These programs include the Summer Undergraduate Research Program, a ten-week research program for outstanding undergraduate students who are interested in pursuing a career in the biomedical sciences; the School of Cytotechnology, a one-year post-baccalaureate certificate program that provides students with a wide range of technical and cytodiagnostic skills; and the School of Radiation Therapy, which offers a two-year, full-time program of study in Radiation Oncology Technology.

How We Rank

  • Best Hospitals – U.S. News & World Report ranked Memorial Sloan Kettering as one of the best hospitals for cancer care in the country and among the nation’s top pediatric hospitals for cancer in its 2013-2014 rankings.
  • With Our Patients – According to the most recent patient satisfaction survey, which reflects patients’ opinions about our care in the third quarter of 2012, we received an average overall hospital rating of 89 out of 100 among inpatients and an overall care and service rating of 95 out of 100 among outpatients.
  • Cancer Survival Outcomes – Quality of patient care is of paramount importance at Memorial Sloan Kettering, where patient survival outcomes are better than the national average, according to the National Cancer Data Base, which contains data from more than 1,400 hospitals across the United States.
  • Among Employers – Crain’s New York Business named Memorial Sloan Kettering one of the largest employers in New York City in 2012.
  • Among National Charities – Forbes named Memorial Sloan Kettering among the 100 largest US charities in 2012.
  • With Hospital Technology – Hospitals & Health Networks named Memorial Sloan Kettering among the country’s most wired hospitals and health systems in the United States for the eighth year in a row in 2012.
  • Performance Improvement – Our nurses set standards and influence decisions concerning quality care, taking the lead with other quality experts in developing nationally recognized best practices to improve quality of care and patient outcomes. For example, our nursing leadership is responsible for taking steps to significantly reduce or eliminate incidences of preventable events – such as patient falls and related injuries, infections, skin pressure ulcers (bed sores), and extraversions (the inadvertent administration of chemotherapy into surrounding tissue).

Where We Work

  • Memorial Hospital – We are well known for our hospital location on the Upper East Side of Manhattan, where we have 470 inpatient beds, 21 state-of-the-art surgical suites, a world-renowned children’s hospital, and a 40,000-square-foot facility that includes the Center for Image-Guided Interventions. We also have many administrative, technical, and support staff members who work in six nonclinical and administrative buildings in Manhattan and in Lyndhurst, New Jersey.
  • Outpatient Facilities – We have 11 outpatient locations throughout Manhattan and one in Brooklyn, as well as outpatient treatment centers in Sleepy Hollow, NY; Commack, NY; Hauppauge, NY; Rockville Centre, NY; and Basking Ridge, NJ. In 2015, we will be opening a sixth regional care site in Harrison, NY.
  • Research Laboratories – We have more than 120 research laboratories in Manhattan that are focused on better understanding cancer, and more than 35 state-of-the-art core facilities that provide our research community with the latest technologies and a wide range of expert services.

How We Are Supported

  • Philanthropy – Memorial Sloan Kettering received more than $231 million in philanthropic support in 2012.
  • Capital Campaign – A Capital Campaign for Memorial Sloan Kettering was launched in 2003 with an original goal of raising $1 billion over five years. Given its early success, the campaign has been extended to a historic fund-raising effort and its goal is now $3.5 billion. As of December 31, 2012, gifts and pledges totaled more than $2.7 billion.
  • Grants and Contracts – We received $185 million in grants and contracts support for our research in 2012, with nearly $140 million coming from the federal government and the remainder from industry and nonprofit sources.
  • Volunteers – More than 1,000 volunteers generously donated nearly 76,000 hours of service in 2012.